Clinical Trial Update: Effect of Saliva Substitutes on Dental Hard Tissues in Situ [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating saliva substitutes for effects on dental hard tissues in individuals with xerostomia (hyposalivation) has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Xerostomia

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Hyposalivation | Phase 2, Phase 3 | Status: TERMINATED